Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. HAO
HAO logo

HAO Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.100
Open
1.100
VWAP
1.10
Vol
830.00
Mkt Cap
65.39M
Low
1.100
Amount
913.00
EV/EBITDA(TTM)
--
Total Shares
59.44M
EV
59.37M
EV/OCF(TTM)
--
P/S(TTM)
--
Haoxi Health Technology Ltd is a China-based holding company principally engaged in the provision of online marketing solutions for customers. The Company's main business is the provision of one-stop advertising marketing solutions like online short video advertisements through its media partners, including planning, production, placement, and optimization of online advertisements. The co-operative media partners of the Company include media platforms (such as Toutiao and Tiktok) and authorized third-party agent media. The Company principally provides its advertising services to companies and customers in the healthcare field. The Company principally conducts its businesses in the domestic market.
Show More

Events Timeline

(ET)
2026-03-03
07:40:00
Haoxi Health Signs Strategic Cooperation Agreement with Global Mofy AI
select
2025-04-21 (ET)
2025-04-21
09:53:32
Haoxi Health Technology launches customized livestreaming agency strategy
select
2025-02-11 (ET)
2025-02-11
07:49:05
Haoxi Health Technology regains compliance with Nasdaq closing bid price rule
select
2025-01-23 (ET)
2025-01-23
07:37:34
Haoxi Health Technology announces 1-for-25 reverse share split
select
2024-11-06 (ET)
2024-11-06
17:35:45
Haoxi Health Technology receives noncompliance letter from Nasdaq
select
2024-10-29 (ET)
2024-10-29
08:35:51
Haoxi Health Technology reports FY24 EPS 4c vs. 4c last year
select
2024-10-07 (ET)
2024-10-07
08:29:10
Haoxi Health Technology sees FY24 revenue $48.52M vs. $28.23M last year
select
2024-09-19 (ET)
2024-09-19
09:28:32
Haoxi Health Technology prices 4M units at $3.00 in follow-on public offering
select

News

Newsfilter
2.0
03-03Newsfilter
Haoxi Health and Eaglepoint AI Sign Strategic Cooperation Agreement
  • Strategic Cooperation Agreement: Haoxi Health and Eaglepoint AI have signed a three-year strategic cooperation agreement, committing joint R&D, data, and channel resources to launch an AI health management platform, marking Haoxi's exploration of new opportunities in the AI healthcare sector.
  • Innovative Technology Application: This collaboration represents the first deployment of Eaglepoint AI's Aquila data engine and multimodal model evaluation system in a health management scenario, expected to enhance the intelligence of health management and drive the development of preventive healthcare applications.
  • Market Promotion Support: Haoxi Health plans to leverage its extensive marketing networks to provide user reach and commercial conversion support, while Eaglepoint AI will handle technical support, including model training and data security compliance, ensuring smooth project execution.
  • Phase One Objectives: The initial phase will launch the
Yahoo Finance
3.0
2025-10-04Yahoo Finance
Concerns Arise Among Investors Regarding Haoxi Health Technology's (NASDAQ:HAO) Capital Returns
  • Haoxi Health Technology's Financial Performance: The company has a low return on capital employed (ROCE) of 4.1%, significantly below the media industry average of 9.5%, indicating underperformance despite an increase in capital employed and revenue.

  • Growth Strategy and Risks: Although Haoxi is reinvesting for growth, leading to higher sales, its stock has plummeted 82% over the past year, suggesting potential underlying issues, including five warning signs that investors should be aware of.

Benzinga
9.5
2025-09-11Benzinga
Oxford Industries Shares Rise Approximately 15%; Check Out 20 Stocks Making Moves in Premarket Trading
  • Oxford Industries Earnings Report: Oxford Industries, Inc. shares rose 15.1% in pre-market trading after reporting Q2 earnings of $1.26 per share, exceeding analyst expectations of $1.18, and raising its FY25 EPS guidance despite a revenue miss.

  • Pre-Market Stock Movements: Several stocks saw significant pre-market trading movements, with YY Group Holding Limited gaining 122.9% and Vince Holding Corp rising 101%, while Robin Energy Ltd. and TOP Financial Group Limited experienced declines of 23.5% and 21.6%, respectively.

Benzinga
2.0
2025-08-27Benzinga
MongoDB Shares Surge 31%; Check Out 20 Stocks Making Moves in Premarket Trading
  • MongoDB's Strong Performance: MongoDB, Inc. shares surged 31% in pre-market trading after reporting better-than-expected second-quarter results and raising its fiscal 2026 adjusted EPS guidance to between $3.64 and $3.73.

  • Other Gainers: Notable pre-market gainers included NovaBay Pharmaceuticals (up 66.7% due to a special cash dividend), Bollinger Innovations (up 32.1%), and BioXcel Therapeutics (up 19.5% after announcing Phase 3 data).

  • Pre-Market Losers: Stocks that declined in pre-market trading included Fenbo Holdings (down 16.8%), SCWorx Corp (down 15.2%), and Beneficient (down 14.3%).

  • Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting significant movements both upward and downward.

Newsfilter
5.0
2025-04-21Newsfilter
Haoxi Health Technology Limited Launches Customized Livestreaming Agency Strategy
  • Company Announcement: Haoxi Health Technology Limited has launched a customized livestreaming agency strategy through its subsidiary, Haoxi Beijing, aimed at enhancing marketing solutions for the medical aesthetics sector in response to growing consumer demand.

  • Service Offerings: The new livestreaming services will provide a comprehensive approach including account setup, content planning, and post-campaign analysis, focusing on long-term brand building and improving online conversion rates for clients in the healthcare industry.

Benzinga
2.0
2025-02-12Benzinga
Why Upstart Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
  • Upstart Holdings Performance: Upstart Holdings, Inc. shares surged 25.5% in pre-market trading after reporting better-than-expected fourth-quarter earnings of 26 cents per share and revenue of $218.96 million, along with optimistic FY25 revenue guidance.

  • Market Movements: Several stocks experienced significant pre-market gains, including Mynaric AG (+75%) and Windtree Therapeutics, Inc. (+57.3%), while others like Spire Global, Inc. saw a dramatic drop of 49.6% following a legal complaint.

Valuation Metrics

The current forward P/E ratio for Haoxi Health Technology Ltd (HAO.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Haoxi Health Technology Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding HAO

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Haoxi Health Technology Ltd (HAO) stock price today?

The current price of HAO is 1.1 USD — it has increased 0

What is Haoxi Health Technology Ltd (HAO)'s business?

Haoxi Health Technology Ltd is a China-based holding company principally engaged in the provision of online marketing solutions for customers. The Company's main business is the provision of one-stop advertising marketing solutions like online short video advertisements through its media partners, including planning, production, placement, and optimization of online advertisements. The co-operative media partners of the Company include media platforms (such as Toutiao and Tiktok) and authorized third-party agent media. The Company principally provides its advertising services to companies and customers in the healthcare field. The Company principally conducts its businesses in the domestic market.

What is the price predicton of HAO Stock?

Wall Street analysts forecast HAO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for HAO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Haoxi Health Technology Ltd (HAO)'s revenue for the last quarter?

Haoxi Health Technology Ltd revenue for the last quarter amounts to 5.67 USD, decreased -22.33

What is Haoxi Health Technology Ltd (HAO)'s earnings per share (EPS) for the last quarter?

Haoxi Health Technology Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Haoxi Health Technology Ltd (HAO). have?

Haoxi Health Technology Ltd (HAO) has 30 emplpoyees as of March 17 2026.

What is Haoxi Health Technology Ltd (HAO) market cap?

Today HAO has the market capitalization of 65.39M USD.